Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TCR Vbeta1 antibody (PerCP-Cy5.5)

Reactivity: Human FACS Host: Mouse Monoclonal BL37-2 PerCP-Cy5.5
Catalog No. ABIN2660244
  • Target
    TCR Vbeta1
    Reactivity
    Human
    Host
    • 5
    Mouse
    Clonality
    • 5
    Monoclonal
    Conjugate
    • 1
    • 1
    • 1
    • 1
    • 1
    PerCP-Cy5.5
    Application
    • 5
    • 3
    • 3
    • 2
    Flow Cytometry (FACS)
    Purification
    The antibody was purified by affinity chromatography and conjugated with PerCP/Cy5.5 under optimal conditions. The solution is free of unconjugated PerCP/Cy5.5 and unconjugated antibody.
    Clone
    BL37-2
    Isotype
    IgG1 kappa
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Buffer
    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    Protect from prolonged exposure to light. Do not freeze.
    Storage
    4 °C
    Storage Comment
    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target
    TCR Vbeta1
    Alternative Name
    TCR V Beta1
    Background
    TCR Vβ1 is a variant of the TCR Vβ chain that is expressed by a subset of αβ+ T cells. Aberrant expression of TCR Vβ chains has been associated with infection and cancer. TCR Vβ1 is reported to be preferably used by autoreactive T cells in a model of autoimmune thyroiditis and diabetes. Skewing of TCR Vβ repertoire to Vβ1 and Vβ9 has also been reported in patients with multiple sclerosis, reactive arthritis, and Kawasaki disease.
You are here:
Support